BASILEA PHARMACEUTICA
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and nonresponse to current treatment options.
BASILEA PHARMACEUTICA
Social Links:
Industry:
Biotechnology Commercial Pharmaceutical
Founded:
2000-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.basilea.com
Total Employee:
101+
Status:
Active
Contact:
41616061112
Email Addresses:
[email protected]
Total Funding:
84.69 M USD
Technology used in webpage:
Domain Not Resolving HSTS Organization Schema ReCAPTCHA V2 IIS PostalAddress Schema DigiCert SSL Smart App Banner IIS 8 Place Schema
Similar Organizations
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Adrenomed
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Destiny Pharma
Destiny Pharma Ltd., a clinical stage pharmaceutical company
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Newron Pharmaceuticals
Newron Pharmaceuticals S.p.A. is a biopharmaceutical company
Kazia Therapeutics
Kazia Therapeutics is an oncology focused biotechnology company.
Oncimmune
Oncimmune engaged in developing and commercializing its EarlyCDT platform technology.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
CARB-X
CARB-X investment in Grant - Basilea Pharmaceutica
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Basilea Pharmaceutica
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Basilea Pharmaceutica
CARB-X
CARB-X investment in Grant - Basilea Pharmaceutica
Official Site Inspections
http://www.basilea.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.29 K
- Host name: basilealb12.nine.ch
- IP address: 5.148.179.212
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Basilea Pharmaceutica"
Who we are : Basilea
Aug 30, 2024 Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. Basilea has about 150 employees. We are committed to …See details»
News : Basilea
Jul 19, 2015 Basilea's Board proposes Martin Nicklasson to succeed Chairman Werner Henrich and recommends to shareholders that they do not support the request for a capital distribution …See details»
Basilea Pharmaceutica - Wikipedia
Basilea Pharmaceutica was founded in 2000 as a corporate spin-off of the pharmaceutical company Roche. In 2002, Chinese subsidiary Basilea Pharmaceutica China Ltd. (BPC) was founded and was located in the Haimen Economic and Technological Development Zone in the city of Nantong in the Chinese province of Jiangsu, north of Shanghai. See details»
Basilea Pharmaceutica - Crunchbase Company Profile & Funding
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial …See details»
Basilea Pharmaceutica AG
Basilea’s relationship with BARDA stretches back to 2013 when the agency committed $89 million in funding toward the antibiotic BAL30072—although the biotech went on to scrap the …See details»
Basilea Pharmaceutica Ltd. – Swiss Biotech
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Basilea is committed to discovering, developing and …See details»
Basilea Pharmaceutica - Overview, News & Similar companies
Oct 28, 2020 Basilea Pharmaceutica contact info: Phone number: +41 616061111 Website: www.basilea.com What does Basilea Pharmaceutica do? Founded in 2000, Basilea …See details»
Basilea Pharmaceutica AG
Basilea’s relationship with BARDA stretches back to 2013 when the agency committed $89 million in funding toward the antibiotic BAL30072—although the biotech went on to scrap the candidate three years later.Basilea CEO David …See details»
Investor center : Basilea
Oct 22, 2024 Organization. What we do. Our portfolio. Disease areas. Our products and pipeline. Investor center. Investing in Basilea. Convertible bonds. Current presentation. ... In …See details»
Basilea Pharmaceutica International Ltd, Allschwil
Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe …See details»
Basilea Pharmaceutica - Contacts, Employees, Board Members
Basilea Pharmaceutica has 15 current employee profiles, including Chief Executive Officer Ronald Scott. Basilea Pharmaceutica has 8 board members and advisors, including Domenico Scala . …See details»
Basilea Pharmaceutica - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
US authority contributes to the costs for Basilea development
Basilea has entered into an Other Transaction Agreement with the Biomedical Advanced Research and Development Authority ().The US agency, which reports to the Administration …See details»
What we do : Basilea
Anti-infectives, specifically antifungals and antibiotics, is the key focus of Basilea’s strategy. We have successfully brought two anti-infective drugs to the market: the antifungal Cresemba …See details»
Glioblastoma Foundation® Acquires Drug Lisavanbulin
Oct 24, 2024 Oncology drug displays potential as therapy for a subset of glioblastoma patients [Durham, NC, October 24, 2024] The Glioblastoma Foundation, the leading national nonprofit …See details»
CARB-X is funding Basilea Pharmaceutica to develop a new class …
Basilea’s new drug targets drug-resistant bacteria identified by the World Health Organization (WHO) as ‘critical’ pathogens against which new antibiotics are urgently needed (BOSTON: …See details»
Reports Archive : Basilea
Feb 14, 2023 Organization. What we do. Our portfolio. Disease areas. Our products and pipeline. Investor center. Investing in Basilea. Convertible bonds. Current presentation. …See details»
The Basel Committee - overview - Bank for International Settlements
The Basel Committee on Banking Supervision (BCBS) is the primary global standard setter for the prudential regulation of banks and provides a forum for regular cooperation on banking …See details»
Careers : Basilea
Become part of Basilea. If you wish to become a part of a multinational, innovative team that strives to make a difference to patients’ outcomes worldwide, we would love to hear from you. …See details»